Abstract
Glucocorticoids play a primary role in the maturation of fetal organs and may contribute to the onset of labour. Glucocorticoid activity depends on the 11β-hydroxysteroid dehydrogenase family (11β-HSDs), catalysing the interconversion between "active" cortisol into inactive cortisone. No definitive study exists on 11β-HSD expression profile in human decidua and myometrium during pregnancy. We investigated the implications of 11β-HSD1 in the regulation of uterine activity in pregnancy, examining its role on contraction of a myocyte cell line and murine 11β-hsd1 levels in utero. Murine 11β-hsd1 mRNA and protein levels in utero progressively increased until the last day of gestation and significantly decreased at the onset of labour (P < 0.0001) (n = 3 to 5 in the various gestational days analysed). Experiments on human myometrial samples confirm the significant fall in 11β-hsd1 mRNA levels at labour, compared to end pregnancy samples (n = 5 to 8). In vitro experiments showed that human myometrial contraction is inhibited by using a non-selective inhibitor of 11β-HSD1. The present study shows the temporal localisation of 11β-HSD1 in uterus, highlighting its importance in the timing of gestation and suggesting its contribution in the myometrium contraction.
Original language | English |
---|---|
Pages (from-to) | 79-86 |
Number of pages | 8 |
Journal | Molecular and Cellular Endocrinology |
Volume | 447 |
DOIs | |
Publication status | Published - 15 May 2017 |
Bibliographical note
Copyright © 2017 Elsevier B.V. All rights reserved.Keywords
- 11-beta-Hydroxysteroid Dehydrogenase Type 1/genetics
- 11-beta-Hydroxysteroid Dehydrogenase Type 2/genetics
- Animals
- Carbenoxolone/pharmacology
- Cell Line
- Female
- Humans
- Labor, Obstetric
- Mice, Inbred C57BL
- Myometrium/drug effects
- Pregnancy
- Time Factors
- Uterine Contraction/drug effects